GILD Stock — Gilead Sciences, Inc.

Gilead Sciences, Inc. (GILD)

Updated October 16, 2026.

GILD is a Stock. its distribution rate is 2.10%, its trailing-12-month yield is 2.08%. Dividend Vision Distribution Safety Score™ is 99/100 (Safe). Total return is 36063.5% over the past 34.7 years.

Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes medicines for HIV, hepatitis B and C, oncology, and other areas of unmet medical need, with a portfolio including antiretroviral therapies, immunotherapies, and cell therapies. The company currently distributes dividends on a quarterly basis at a modest current distribution rate. Gilead appeals to income-focused investors seeking exposure to the pharmaceutical sector with regular dividend payments.

GILD performance

Price and return data through 2026-10-16.

Total return is 36063.5% over the past 34.7 years. Over the past year its total return — price change plus distributions reinvested — is 35.8%. Its deepest 1-year drawdown was 21.6%.

GILD key facts

Distribution Safety Score™

99 · Safe

Safety-Adjusted Yield

2.08%

Asset type

Stock

Asset class

Equity

Inception date

01/22/1992

Distribution rate

2.10%

Distribution frequency

Quarterly

Trailing yield

2.08%

5-year average yield

3.32

Last close

$156.19 (as of 2026-10-16)

Market cap

$193,668,595,659

Average volume

7770900.0

Dividend

$0.82

Ex-dividend date

09/15/2026

Payment date

09/29/2026

Beta

0.332

Payout ratio

43.5%

Forward P/E

15.5521

EPS

$-2.65

How Dividend Vision calculates yield and returns

Distribution rate (2.10%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (2.08%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

GILD risks and drawbacks

GILD's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 21.6%.

Who may consider GILD — and who may not

GILD may suit someone looking for a high Distribution Safety Score, moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (GILD pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on GILD

• ETFs holding GILD
• All tickers starting with G

Tagged: Dividend, Pharmaceutical.

Frequently asked questions